DOTAREM 376.9 mg/mL
gadoterate meglumine · INJECTION · Guerbet LLC
No Recall HistoryCurrently in Shortage
Plain English
DOTAREM is a injection containing gadoterate meglumine at 376.9 mg/mL, taken intravenous. Manufactured by Guerbet LLC.
Key Facts
- Brand Name
- DOTAREM
- Generic Name
- gadoterate meglumine
- NDC Code (Product)
67684-2000- Manufacturer
- Guerbet LLC
- Strength
- 376.9 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA204781
- Marketing Start
- 04/26/2013
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
urticaria589 reports
dyspnoea474 reports
nausea453 reports
pruritus435 reports
vomiting370 reports
erythema361 reports
cough255 reports
rash244 reports
product use in unapproved indication191 reports
headache180 reports
Frequently Asked Questions
What is DOTAREM used for?
DOTAREM contains gadoterate meglumine. It is a injection taken intravenous. Consult your doctor for specific uses.
Is DOTAREM a controlled substance?
DOTAREM is not classified as a controlled substance by the DEA.
What is the generic name for DOTAREM?
The generic name for DOTAREM is gadoterate meglumine. There are 7 other brand versions of gadoterate meglumine.
What is the NDC code for DOTAREM 376.9 mg/mL?
The NDC (National Drug Code) for DOTAREM 376.9 mg/mL is 67684-2000, listed by Guerbet LLC.